click tracking
Swiss Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 241 - 260 out of 277 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14 »

CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

Read more ››
By: Nasdaq / GlobenewsWire - 19 Feb 2019
Related companies:  CRISPR Therapeutics AG

Novo Nordisk receives US FDA approval of ESPEROCT® (turoctocog alfa pegol, N8-GP)

Read more ››
By: Nasdaq / GlobenewsWire - 19 Feb 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 18 Feb 2019

Lundbeck increases its share capital by 5,631 shares (0.0028 % of outstanding shares) as a result of exercise of employee warrants

Read more ››
By: Nasdaq / GlobenewsWire - 18 Feb 2019

Spring Pharmaceutical Group Inc. Reports Financial Results for the Three and Nine Months Ended December 31, 2018

JINING, China, Feb. 14, 2019 /PRNewswire/ -- Spring Pharmaceutical Group, Inc. (OTCQB: CYIG) ("Spring Pharmaceutical" or the "Company") today announced its financial results for the three and nine months ended December 31, 2018.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2019

Lundbeck and Otsuka report phase III data evaluating brexpiprazole for the treatment of manic episodes associated with bipolar I disorder

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019

Addex and Indivior to Accelerate Additional GABAB PAM Compounds for Addiction as Indivior Elects to Stop Development of ADX71441

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2019
Related companies:  Addex Therapeutics S.A.

SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe

GYEONGGI, South Korea, Feb. 14, 2019 /PRNewswire/ -- SK Biopharmaceuticals and Arvelle Therapeutics GmbH today announced that they have entered into an exclusive licensing agreement for Arvelle to develop and commercialize cenobamate in Europe. Cenobamate is a novel, small molecule investigational... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2019

Trading in Novo Nordisk shares by board members, executives and associated persons on 12 February 2019

Read more ››
By: Nasdaq / GlobenewsWire - 13 Feb 2019

Information concerning the total number of voting rights and shares

Read more ››
By: Nasdaq / GlobenewsWire - 12 Feb 2019

Sanofi appoints Ameet Nathwani Chief Digital Officer

Read more ››
By: Nasdaq / GlobenewsWire - 12 Feb 2019

Novo Nordisk A/S - Share repurchase programme

Read more ››
By: Nasdaq / GlobenewsWire - 11 Feb 2019

Auris Medical Announces Receipt of Nasdaq Notice

Read more ››
By: Nasdaq / GlobenewsWire - 08 Feb 2019
Related companies:  Auris Medical AG

Strong European Cresemba® (isavuconazole) sales trigger USD 5 million milestone payment to Basilea from Pfizer

Read more ››
By: Nasdaq / GlobenewsWire - 08 Feb 2019
Related companies:  Basilea Pharmaceutica Ltd | Basilea Pharmaceutica Deutschland GmbH

Myovant Provides Corporate Updates and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2018

BASEL, Switzerland, Feb. 7, 2019 /PRNewswire/ -- Myovant Sciences (NYSE: MYOV), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of women's health and endocrine diseases, today announced corporate updates and reported... Read more ››

By: PR Newswire Association LLC. - 07 Feb 2019
Related companies:  Myovant Sciences GmbH

Basilea announces change in the Management Committee - Adesh Kaul appointed CFO

Read more ››
By: Nasdaq / GlobenewsWire - 07 Feb 2019
Related companies:  Basilea Pharmaceutica Ltd | Basilea Pharmaceutica Deutschland GmbH

Sanofi delivers 2018 business EPS growth of 5.1% at CER

Read more ››
By: Nasdaq / GlobenewsWire - 07 Feb 2019

Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

Read more ››
By: Nasdaq / GlobenewsWire - 06 Feb 2019

Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

Read more ››
By: Nasdaq / GlobenewsWire - 06 Feb 2019

Lundbeck realized 8% growth in revenue (local currencies) and 48% growth in EPS in 2018

Read more ››
By: Nasdaq / GlobenewsWire - 05 Feb 2019
«  1  2  3  4  5  6  7  8  9  10  11  12 13  14 »

Looking for companies outside of Switzerland?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • September 2019
    • Boston: 9th Annual American Drug Delivery & Formulation Summit
    • Malmo: NLS Days 2019
    • Boston: Redefining Early Stage Investments (RESI)
See Events »
Add an Event »

Latest company news

Qu Biologics publishes potentially paradigm-shifting results of their first randomized-placebo controlled trial for the treatment of Crohn’s disease
23 Jul 2019 (Nasdaq / GlobenewsWire)

Idorsia announces financial results for the first half of 2019
23 Jul 2019 (Nasdaq / GlobenewsWire)

Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu® in Flu Care
23 Jul 2019 (Nasdaq / GlobenewsWire)

Biotechgate database

About Biotechgate
The Swiss Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com